PALO ALTO, Calif., April 3, 2017 /ja/PRNewswire/ja/ -- Varian Medical Systems (NYSE: VAR) today announced that it has reached a confidential settlement agreement with Elekta (EKTA-B) to end ongoing patent litigation involving technology used for radiation oncology and the treatment of cancer. Varian and Elekta resolved the multi-year disputes in the United States, Germany, and the United Kingdom, including the suit brought by Elekta AB and William Beaumont Hospital, with no payments exchanged by the plaintiffs and defendants and no future financial obligations. The two companies have been in litigation since 2015.
About Varian Medical Systems Press Contact SOURCE Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,400 people at sites around the world. For more information, visit http:/ja//ja/www.varian.com and follow @VarianMedSys on Twitter.
Varian Medical Systems
+1 (650) 424-5782
Press Contact SOURCE Varian Medical Systems
SOURCE Varian Medical Systems